- Home
- DCGO vs SGMO Comparison
DCGO vs SGMO Comparison
Compare DCGO & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- SGMO
- Stock Information
- Founded
- DCGO 2015
- SGMO 1995
- Country
- DCGO United States
- SGMO United States
- Employees
- DCGO N/A
- SGMO N/A
- Industry
- DCGO Managed Health Care
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DCGO Health Care
- SGMO Health Care
- Exchange
- DCGO Nasdaq
- SGMO Nasdaq
- Market Cap
- DCGO 144.7M
- SGMO 122.8M
- IPO Year
- DCGO N/A
- SGMO 2000
- Fundamental
- Price
- DCGO $1.46
- SGMO $0.59
- Analyst Decision
- DCGO Strong Buy
- SGMO Buy
- Analyst Count
- DCGO 4
- SGMO 6
- Target Price
- DCGO $3.74
- SGMO $4.50
- AVG Volume (30 Days)
- DCGO 543.9K
- SGMO 5.2M
- Earning Date
- DCGO 08-07-2025
- SGMO 08-05-2025
- Dividend Yield
- DCGO N/A
- SGMO N/A
- EPS Growth
- DCGO N/A
- SGMO N/A
- EPS
- DCGO N/A
- SGMO N/A
- Revenue
- DCGO $520,500,658.00
- SGMO $63,756,000.00
- Revenue This Year
- DCGO N/A
- SGMO $1.29
- Revenue Next Year
- DCGO $4.08
- SGMO $1.60
- P/E Ratio
- DCGO N/A
- SGMO N/A
- Revenue Growth
- DCGO N/A
- SGMO 239.92
- 52 Week Low
- DCGO $1.23
- SGMO $0.41
- 52 Week High
- DCGO $5.68
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- DCGO 45.62
- SGMO 60.91
- Support Level
- DCGO $1.40
- SGMO $0.50
- Resistance Level
- DCGO $1.57
- SGMO $0.65
- Average True Range (ATR)
- DCGO 0.08
- SGMO 0.04
- MACD
- DCGO 0.00
- SGMO 0.01
- Stochastic Oscillator
- DCGO 34.04
- SGMO 64.22
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.